Store Site
Friday, December 10, 2010
New Subgroup Analysis Of The LUX-Lung 1 Trial Suggests Benefit From Afatinib In Lung Cancer Patients Likely To Have...
http://ping.fm/8K9on
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment